Literature DB >> 22188108

Chronic cigarette smoking alters circulating sex hormones and neuroactive steroids in premenopausal women.

M Dušková1, K Simůnková, M Hill, M Velíková, J Kubátová, L Kancheva, H Kazihnitková, H Hruškovičová, H Pospíšilová, B Rácz, M Salátová, V Cirmanová, E Králíková, L Stárka, A Pařízek.   

Abstract

Chronic smoking alters the circulating levels of sex hormones and possibly also the neuroactive steroids. However, the data available is limited. Therefore, a broad spectrum of free and conjugated steroids and related substances was quantified by GC-MS and RIA in premenopausal smokers and in age-matched (38.9+/-7.3 years of age) non-smokers in the follicular (FP) and luteal phases (LP) of menstrual cycle (10 non-smokers and 10 smokers, in the FP, and 10 non-smokers and 8 smokers in the LP). Smokers in both phases of the menstrual cycle showed higher levels of conjugated 17-hydroxypregnenolone, 5alpha-dihydroprogesterone, conjugated isopregnanolone, conjugated 5alpha-pregnane-3beta,20alpha-diol, conjugated androstenediol, androstenedione, testosterone, free testosterone, conjugated 5alpha-androstane-3alpha/beta,17beta-diols, and higher free testosterone index. In the FP, the smokers exhibited higher levels of conjugated pregnenolone, progesterone, conjugated pregnanolone, lutropin, and a higher lutropin/follitropin ratio, but lower levels of cortisol, allopregnanolone, and pregnanolone. In the LP, the smokers exhibited higher levels of free and conjugated 20alpha-dihydropregnenolone, free and conjugated dehydroepiandrosterone, free androstenediol, 5alpha-dihydrotestosterone, free and conjugated androsterone, free and conjugated epiandrosterone, free and conjugated etiocholanolone, 7alpha/beta-hydroxy-dehydroepiandrosterone isomers, and follitropin but lower levels of estradiol and sex hormone binding globulin (SHBG) and lower values of the lutropin/follitropin ratio. In conclusion, chronic cigarette smoking augments serum androgens and their 5alpha/beta-reduced metabolites (including GABAergic substances) but suppresses the levels of estradiol in the LP and SHBG and may induce hyperandrogenism in female smokers. The female smokers had pronouncedly increased serum progestogens but paradoxically suppressed levels of their GABA-ergic metabolites. Further investigation is needed concerning these effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188108     DOI: 10.33549/physiolres.932164

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  8 in total

1.  Prospective evaluation of luteal phase length and natural fertility.

Authors:  Natalie M Crawford; David A Pritchard; Amy H Herring; Anne Z Steiner
Journal:  Fertil Steril       Date:  2017-01-05       Impact factor: 7.329

2.  Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.

Authors:  Ashley S Felix; Hannah P Yang; Gretchen L Gierach; Yikyung Park; Louise A Brinton
Journal:  Cancer Causes Control       Date:  2014-02-01       Impact factor: 2.506

3.  Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking.

Authors:  Alicia M Allen; Cheryl Oncken; Dorothy Hatsukami
Journal:  Curr Addict Rep       Date:  2014-01-10

4.  Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families.

Authors:  Carolina Ellberg; Håkan Olsson; Helena Jernström
Journal:  Cancer Causes Control       Date:  2018-01-03       Impact factor: 2.506

5.  Effect of the thymine-DNA glycosylase rs4135050 variant on Saudi smoker population.

Authors:  Mikhlid Almutairi; Abdullah Mohammad Alhadeq; Rafa Almeer; Mohammed Almutairi; Mohammed Alzahrani; Abdelhabib Semlali
Journal:  Mol Genet Genomic Med       Date:  2019-02-18       Impact factor: 2.183

6.  Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema.

Authors:  Lucas A Gillenwater; Katerina J Kechris; Katherine A Pratte; Nichole Reisdorph; Irina Petrache; Wassim W Labaki; Wanda O'Neal; Jerry A Krishnan; Victor E Ortega; Dawn L DeMeo; Russell P Bowler
Journal:  Metabolites       Date:  2021-03-11

7.  The protective effects of the methylenetetrahydrofolate reductase rs1801131 variant among Saudi smokers.

Authors:  Mikhlid H Almutairi; Nouf S Al-Numair; Narasimha Reddy Parine; Bader O Almutairi; Abdulwahed F Alrefaei; Mahmoud Rouabhia; Abdelhabib Semlali
Journal:  Saudi J Biol Sci       Date:  2021-04-13       Impact factor: 4.219

8.  No difference in hypertension prevalence in smokers, former smokers and non-smokers after adjusting for body mass index and age: a cross-sectional study from the Czech Republic, 2010.

Authors:  Alexandra Pankova; Eva Kralikova; Keely Fraser; Jan Lajka; Stepan Svacina; Martin Matoulek
Journal:  Tob Induc Dis       Date:  2015-08-11       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.